Functional imaging for prostate cancer: therapeutic implications.
Functional imaging for prostate cancer: therapeutic implications.
复制标题
DOI:
10.1053/j.semnuclmed.2012.04.004
复制
发表时间:
2012-09
影响因子:
4.9
通讯作者:
Seo Y
中科院分区:
文献类型:
--
作者:
Mari Aparici C;Seo Y
Functional radionuclide imaging modalities, now commonly combined with anatomical imaging modalities CT or MRI (SPECT/CT, PET/CT, and PET/MRI) are promising tools for the management of prostate cancer particularly for therapeutic implications. Sensitive detection capability of prostate cancer using these imaging modalities is one issue; however, the treatment of prostate cancer using the information that can be obtained from functional radionuclide imaging techniques is another challenging area. There are not many SPECT or PET radiotracers that can cover the full spectrum of the management of prostate cancer from initial detection, to staging, prognosis predictor, and all the way to treatment response assessment. However, when used appropriately, the information from functional radionuclide imaging improves, and sometimes significantly changes, the whole course of the cancer management. The limitations of using SPECT and PET radiotracers with regards to therapeutic implications are not so much different from their limitations solely for the task of detecting prostate cancer; however, the specific imaging target and how this target is reliably imaged by SPECT and PET can potentially make significant impact in the treatment of prostate cancer. Finally, while the localized prostate cancer is considered manageable, there is still significant need for improvement in noninvasive imaging of metastatic prostate cancer, in treatment guidance, and in response assessment from functional imaging including radionuclide-based techniques. In this review article, we present the rationale of using functional radionuclide imaging and the therapeutic implications for each of radionuclide imaging agent that have been studied in human subjects.
登录
查看更多内容
影响因子:
7.3
作者:
Banerjee SR;Pullambhatla M;Byun Y;Nimmagadda S;Green G;Fox JJ;Horti A;Mease RC;Pomper MG
通讯作者:
Pomper MG
DOI:
10.1007/s00259-007-0516-0
发表时间:
2008-01-01
影响因子:
9.1
作者:
Brenot-Rossi, Isabelle;Rossi, Dominique;Bastide, Cyrille
通讯作者:
Bastide, Cyrille
影响因子:
4.5
作者:
Abdollah, Firas;Schmitges, Jan;Karakiewicz, Pierre I.
通讯作者:
Karakiewicz, Pierre I.
DOI:
10.2967/jnumed.109.066159
发表时间:
2010-02
期刊:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine
影响因子:
--
作者:
Beattie BJ;Smith-Jones PM;Jhanwar YS;Schöder H;Schmidtlein CR;Morris MJ;Zanzonico P;Squire O;Meirelles GS;Finn R;Namavari M;Cai S;Scher HI;Larson SM;Humm JL
通讯作者:
Humm JL
影响因子:
6.6
作者:
Bander, NH;Trabulsi, EJ;Goldsmith, SJ
通讯作者:
Goldsmith, SJ